Company / Current Assets per Share
C4 Therapeutics, Inc. Current Assets per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$3.65
FY2025
5-year range
$3.65 / $5.91
FY2022-FY2025
Trend
-14.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Assets per Share has declined for 3 consecutive years, from $5.91 in FY2022 to $3.65 in FY2025.
Based on SEC 10-K filings.
3.65 in FY2025 with a 3-year CAGR of -14.8%.
Declined from $5.54 to $3.65 over the past 2 years.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -14.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- C4 Therapeutics, Inc.'s current assets per share has declined for 3 consecutive years.
- In FY2025, current assets per share decreased 14.3% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.65 | -14.3% |
| FY2024 | $4.26 | -23.0% |
| FY2023 | $5.54 | -6.2% |
| FY2022 | $5.91 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026